🔗 Share this article

A shadow market for unlicensed slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Investigational Drug Gaining Traction Via Social Media

Retatrutide, which remains in research studies, is being promoted by social media influencers for its supposed fat-burning properties. Viewers are encouraged to message these accounts directly for source information, while also obtaining discount codes.

Active Commerce on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where groups with numerous of participants share “before and after” photos, injection guides and claims of next-day UK delivery. Sellers market the substance there before redirecting customers to other platforms for transactions.

Learning About Retatrutide

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Medical Experts Voice Concerns

Nevertheless, physicians and pharmacists have warned that the distribution of what is still an unapproved medication in the UK is a cause for concern and could lead to users administering substances of uncertain source.

Some experts stated the demand for the experimental drug could be connected to the increasing price of licensed slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed drug that must not be marketed or supplied for human use under the British medical regulations.

Some influencers try to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still breach medicines, marketing, and consumer regulations, risking fines, prosecution or prison.

Platform Response and Content Removal

According to the social media company, the platform has removed violative content and prohibited related hashtags and search suggestions. The company said it was committed to maintaining the platform safe and allocating resources in enhancing enforcement strategies.

Online Trading Activities

Research also discovered groups with up to 9,000 participants marketing retatrutide using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately displays channels with numerous of users, populated with photos of weight loss, glowing testimonials and step-by-step guides for mixing or injecting at residence.

Within moments of entering one community, a seller shared WhatsApp details, where the majority of purchases occur. The vendor provided an guidebook and promised shipping within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about weight, health issues or past usage.

Product Information and Pricing

Inside these communities, messages display dark colored parcels with Royal Mail stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with purified liquid, or pre-filled pens usually sold at 160 pounds for 20mg. When asked how long a pen should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A representative for the messaging service said it actively monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering substances they can’t verify. Even if the research behind retatrutide is sound, these online versions may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in interest to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs increasing, individuals are using social media. But fake injections are highly risky. You cannot know what’s contained or whether the conditions they were produced in was clean,” she said.

Her staff has already encountered individuals harmed by self-injection from unconfirmed sources. “We understand the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company investigational product not yet approved … may expose users to possibly significant health risks”.